{"disease":{"id":"renal-osteodystrophy","name":"Renal osteodystrophy","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":5,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"sevelamer-carbonate","indication_name":"Renal Osteodystrophy with Hyperphosphatemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Renvela","generic_name":"SEVELAMER CARBONATE","company_name":"Sanofi","drug_phase":"marketed","molecular_target":"","drug_class":"Phosphate Binder","quality_score":60,"revenue":null,"mechanism":"Renvela works by binding to dietary phosphate in the gut, preventing its absorption into the bloodstream."},{"drug_id":"alfacalcidol","indication_name":"Renal osteodystrophy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Alfarol","generic_name":"ALFACALCIDOL","company_name":"","drug_phase":"discontinued","molecular_target":"Sodium-dependent noradrenaline transporter","drug_class":"alfacalcidol","quality_score":null,"revenue":null,"mechanism":"Alfarol works by activating vitamin D receptors in the body, which helps regulate calcium levels."},{"drug_id":"renvela","indication_name":"Renal Osteodystrophy with Hyperphosphatemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Renvela","company_name":"Ardelyx","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":12,"revenue":null,"mechanism":null},{"drug_id":"calcitriol","indication_name":"Renal osteodystrophy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Calcijex","generic_name":"CALCITRIOL","company_name":"Esjay Pharma","drug_phase":"marketed","molecular_target":"Vitamin D3 receptor","drug_class":"Vitamin D3 Analog [EPC]","quality_score":60,"revenue":null,"mechanism":""},{"drug_id":"calcifediol","indication_name":"Renal osteodystrophy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Rayaldee","generic_name":"CALCIFEDIOL","company_name":"","drug_phase":"marketed","molecular_target":"Sterol regulatory element-binding protein 1","drug_class":"calcifediol","quality_score":10,"revenue":null,"mechanism":"Rayaldee works by increasing the levels of active vitamin D in the body."},{"drug_id":"calcium-acetate","indication_name":"Renal Osteodystrophy with Hyperphosphatemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Phoslo","generic_name":"CALCIUM ACETATE","company_name":"Fresenius Medcl Care","drug_phase":"marketed","molecular_target":"","drug_class":"calcium acetate","quality_score":75,"revenue":null,"mechanism":"Phoslo works by increasing calcium levels in the blood to treat conditions related to low calcium."},{"drug_id":"rocaltrol","indication_name":"Renal osteodystrophy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Rocaltrol","company_name":"Shandong University","drug_phase":"marketed","molecular_target":"Vitamin D 25-hydroxylase, 25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial, Vitamin D-binding protein","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"alphacalcidol","indication_name":"Renal osteodystrophy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Alphacalcidol","company_name":"University of Ioannina","drug_phase":"phase_2","molecular_target":"Sodium-dependent noradrenaline transporter, Vitamin D3 receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":8,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03626246","title":"Pathogenesis of Compromised Bone Quality and Mechanics in Chronic Kidney Disease","phase":"","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Columbia University","has_results":false},{"nct_id":"NCT05880914","title":"Precision Medicine Approaches to Renal Osteodystrophy","phase":"","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Thomas Nickolas","has_results":false},{"nct_id":"NCT03960437","title":"The Effect of Etelcalcetide on CKD-MBD","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":22,"lead_sponsor_name":"Thomas Nickolas, MD MS","has_results":true},{"nct_id":"NCT03960554","title":"The Effects of 12-months of Denosumab on Bone Density in Prevalent Kidney Transplant Recipients","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":8,"lead_sponsor_name":"Thomas Nickolas, MD MS","has_results":true}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}